img

Global Ophthalmic Viscoelastic Agent Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ophthalmic Viscoelastic Agent Market Research Report 2024

Highlights
The global Ophthalmic Viscoelastic Agent market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2034, witnessing a CAGR of % during the forecast period 2024-2034. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Ophthalmic Viscoelastic Agent is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
Asia-Pacific market for Ophthalmic Viscoelastic Agent is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The key global manufacturers of Ophthalmic Viscoelastic Agent include Alcon Inc, Shanghai Haohai Biological Technology, Bausch & Lomb Inc, Abbott Medical Optics,Inc., LG Life Sciences, Johnson & Johnson Vision, Zeiss, Ellex Medical Laser Limited and Huvitz Co., Ltd., etc. in 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Viscoelastic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Viscoelastic Agent.
The Ophthalmic Viscoelastic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Grams) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2018 to 2034. This report segments the global Ophthalmic Viscoelastic Agent market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Viscoelastic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.



By Company


Alcon Inc
Shanghai Haohai Biological Technology
Bausch & Lomb Inc
Abbott Medical Optics,Inc.
LG Life Sciences
Johnson & Johnson Vision
Zeiss
Ellex Medical Laser Limited
Huvitz Co., Ltd.
Iridex Corp.
Lumenis Ltd.
Nidek Co. Ltd
Topcon Corporation
Visionix Ltd
Eyebright Medical
Segment by Type
Cohesive Viscoelastic
Low Viscosity Dispersion Viscoelastic

Segment by Application


Cataract Surgery
Myopia Surgery
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Detailed analysis of Ophthalmic Viscoelastic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3Sales, revenue of Ophthalmic Viscoelastic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ophthalmic Viscoelastic Agent market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Viscoelastic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Ophthalmic Viscoelastic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Ophthalmic Viscoelastic Agent industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Viscoelastic Agent.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Detailed analysis of Ophthalmic Viscoelastic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3Sales, revenue of Ophthalmic Viscoelastic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8Analysis of sales channel, distributors and customers
Chapter 9Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11The main points and conclusions of the report.

Table of Content

1 Ophthalmic Viscoelastic Agent Market Overview
1.1 Product Overview and Scope of Ophthalmic Viscoelastic Agent
1.2 Ophthalmic Viscoelastic Agent Segment by Type
1.2.1 Global Ophthalmic Viscoelastic Agent Market Value Comparison by Type (2024-2034)
1.2.2 Cohesive Viscoelastic
1.2.3 Low Viscosity Dispersion Viscoelastic
1.3 Ophthalmic Viscoelastic Agent Segment by Application
1.3.1 Global Ophthalmic Viscoelastic Agent Market Value by Application: (2024-2034)
1.3.2 Cataract Surgery
1.3.3 Myopia Surgery
1.3.4 Other
1.4 Global Ophthalmic Viscoelastic Agent Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Viscoelastic Agent Revenue 2018-2034
1.4.2 Global Ophthalmic Viscoelastic Agent Sales 2018-2034
1.4.3 Global Ophthalmic Viscoelastic Agent Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Ophthalmic Viscoelastic Agent Market Competition by Manufacturers
2.1 Global Ophthalmic Viscoelastic Agent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Ophthalmic Viscoelastic Agent Average Price by Manufacturers (2018-2023)
2.4 Global Ophthalmic Viscoelastic Agent Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Product Type & Application
2.7 Ophthalmic Viscoelastic Agent Market Competitive Situation and Trends
2.7.1 Ophthalmic Viscoelastic Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Viscoelastic Agent Players Market Share by Revenue
2.7.3 Global Ophthalmic Viscoelastic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmic Viscoelastic Agent Retrospective Market Scenario by Region
3.1 Global Ophthalmic Viscoelastic Agent Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Ophthalmic Viscoelastic Agent Global Ophthalmic Viscoelastic Agent Sales by Region: 2018-2034
3.2.1 Global Ophthalmic Viscoelastic Agent Sales by Region: 2018-2023
3.2.2 Global Ophthalmic Viscoelastic Agent Sales by Region: 2024-2034
3.3 Global Ophthalmic Viscoelastic Agent Global Ophthalmic Viscoelastic Agent Revenue by Region: 2018-2034
3.3.1 Global Ophthalmic Viscoelastic Agent Revenue by Region: 2018-2023
3.3.2 Global Ophthalmic Viscoelastic Agent Revenue by Region: 2024-2034
3.4 North America Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.4.1 North America Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Ophthalmic Viscoelastic Agent Sales by Country (2018-2034)
3.4.3 North America Ophthalmic Viscoelastic Agent Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Ophthalmic Viscoelastic Agent Sales by Country (2018-2034)
3.5.3 Europe Ophthalmic Viscoelastic Agent Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Ophthalmic Viscoelastic Agent Sales by Country (2018-2034)
3.6.3 Asia Pacific Ophthalmic Viscoelastic Agent Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Ophthalmic Viscoelastic Agent Sales by Country (2018-2034)
3.7.3 Latin America Ophthalmic Viscoelastic Agent Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Viscoelastic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Viscoelastic Agent Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Ophthalmic Viscoelastic Agent Sales by Country (2018-2034)
3.8.3 Middle East and Africa Ophthalmic Viscoelastic Agent Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmic Viscoelastic Agent Sales by Type (2018-2034)
4.1.1 Global Ophthalmic Viscoelastic Agent Sales by Type (2018-2023)
4.1.2 Global Ophthalmic Viscoelastic Agent Sales by Type (2024-2034)
4.1.3 Global Ophthalmic Viscoelastic Agent Sales Market Share by Type (2018-2034)
4.2 Global Ophthalmic Viscoelastic Agent Revenue by Type (2018-2034)
4.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Type (2018-2023)
4.2.2 Global Ophthalmic Viscoelastic Agent Revenue by Type (2024-2034)
4.2.3 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Type (2018-2034)
4.3 Global Ophthalmic Viscoelastic Agent Price by Type (2018-2034)
5 Segment by Application
5.1 Global Ophthalmic Viscoelastic Agent Sales by Application (2018-2034)
5.1.1 Global Ophthalmic Viscoelastic Agent Sales by Application (2018-2023)
5.1.2 Global Ophthalmic Viscoelastic Agent Sales by Application (2024-2034)
5.1.3 Global Ophthalmic Viscoelastic Agent Sales Market Share by Application (2018-2034)
5.2 Global Ophthalmic Viscoelastic Agent Revenue by Application (2018-2034)
5.2.1 Global Ophthalmic Viscoelastic Agent Revenue by Application (2018-2023)
5.2.2 Global Ophthalmic Viscoelastic Agent Revenue by Application (2024-2034)
5.2.3 Global Ophthalmic Viscoelastic Agent Revenue Market Share by Application (2018-2034)
5.3 Global Ophthalmic Viscoelastic Agent Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Alcon Inc
6.1.1 Alcon Inc Corporation Information
6.1.2 Alcon Inc Description and Business Overview
6.1.3 Alcon Inc Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Alcon Inc Ophthalmic Viscoelastic Agent Product Portfolio
6.1.5 Alcon Inc Recent Developments/Updates
6.2 Shanghai Haohai Biological Technology
6.2.1 Shanghai Haohai Biological Technology Corporation Information
6.2.2 Shanghai Haohai Biological Technology Description and Business Overview
6.2.3 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Product Portfolio
6.2.5 Shanghai Haohai Biological Technology Recent Developments/Updates
6.3 Bausch & Lomb Inc
6.3.1 Bausch & Lomb Inc Corporation Information
6.3.2 Bausch & Lomb Inc Description and Business Overview
6.3.3 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Product Portfolio
6.3.5 Bausch & Lomb Inc Recent Developments/Updates
6.4 Abbott Medical Optics,Inc.
6.4.1 Abbott Medical Optics,Inc. Corporation Information
6.4.2 Abbott Medical Optics,Inc. Description and Business Overview
6.4.3 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Product Portfolio
6.4.5 Abbott Medical Optics,Inc. Recent Developments/Updates
6.5 LG Life Sciences
6.5.1 LG Life Sciences Corporation Information
6.5.2 LG Life Sciences Description and Business Overview
6.5.3 LG Life Sciences Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LG Life Sciences Ophthalmic Viscoelastic Agent Product Portfolio
6.5.5 LG Life Sciences Recent Developments/Updates
6.6 Johnson & Johnson Vision
6.6.1 Johnson & Johnson Vision Corporation Information
6.6.2 Johnson & Johnson Vision Description and Business Overview
6.6.3 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Product Portfolio
6.6.5 Johnson & Johnson Vision Recent Developments/Updates
6.7 Zeiss
6.6.1 Zeiss Corporation Information
6.6.2 Zeiss Description and Business Overview
6.6.3 Zeiss Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zeiss Ophthalmic Viscoelastic Agent Product Portfolio
6.7.5 Zeiss Recent Developments/Updates
6.8 Ellex Medical Laser Limited
6.8.1 Ellex Medical Laser Limited Corporation Information
6.8.2 Ellex Medical Laser Limited Description and Business Overview
6.8.3 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Product Portfolio
6.8.5 Ellex Medical Laser Limited Recent Developments/Updates
6.9 Huvitz Co., Ltd.
6.9.1 Huvitz Co., Ltd. Corporation Information
6.9.2 Huvitz Co., Ltd. Description and Business Overview
6.9.3 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Product Portfolio
6.9.5 Huvitz Co., Ltd. Recent Developments/Updates
6.10 Iridex Corp.
6.10.1 Iridex Corp. Corporation Information
6.10.2 Iridex Corp. Description and Business Overview
6.10.3 Iridex Corp. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Iridex Corp. Ophthalmic Viscoelastic Agent Product Portfolio
6.10.5 Iridex Corp. Recent Developments/Updates
6.11 Lumenis Ltd.
6.11.1 Lumenis Ltd. Corporation Information
6.11.2 Lumenis Ltd. Ophthalmic Viscoelastic Agent Description and Business Overview
6.11.3 Lumenis Ltd. Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lumenis Ltd. Ophthalmic Viscoelastic Agent Product Portfolio
6.11.5 Lumenis Ltd. Recent Developments/Updates
6.12 Nidek Co. Ltd
6.12.1 Nidek Co. Ltd Corporation Information
6.12.2 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Description and Business Overview
6.12.3 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Nidek Co. Ltd Ophthalmic Viscoelastic Agent Product Portfolio
6.12.5 Nidek Co. Ltd Recent Developments/Updates
6.13 Topcon Corporation
6.13.1 Topcon Corporation Corporation Information
6.13.2 Topcon Corporation Ophthalmic Viscoelastic Agent Description and Business Overview
6.13.3 Topcon Corporation Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Topcon Corporation Ophthalmic Viscoelastic Agent Product Portfolio
6.13.5 Topcon Corporation Recent Developments/Updates
6.14 Visionix Ltd
6.14.1 Visionix Ltd Corporation Information
6.14.2 Visionix Ltd Ophthalmic Viscoelastic Agent Description and Business Overview
6.14.3 Visionix Ltd Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Visionix Ltd Ophthalmic Viscoelastic Agent Product Portfolio
6.14.5 Visionix Ltd Recent Developments/Updates
6.15 Eyebright Medical
6.15.1 Eyebright Medical Corporation Information
6.15.2 Eyebright Medical Ophthalmic Viscoelastic Agent Description and Business Overview
6.15.3 Eyebright Medical Ophthalmic Viscoelastic Agent Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Eyebright Medical Ophthalmic Viscoelastic Agent Product Portfolio
6.15.5 Eyebright Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Viscoelastic Agent Industry Chain Analysis
7.2 Ophthalmic Viscoelastic Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Viscoelastic Agent Production Mode & Process
7.4 Ophthalmic Viscoelastic Agent Sales and Marketing
7.4.1 Ophthalmic Viscoelastic Agent Sales Channels
7.4.2 Ophthalmic Viscoelastic Agent Distributors
7.5 Ophthalmic Viscoelastic Agent Customers
8 Ophthalmic Viscoelastic Agent Market Dynamics
8.1 Ophthalmic Viscoelastic Agent Industry Trends
8.2 Ophthalmic Viscoelastic Agent Market Drivers
8.3 Ophthalmic Viscoelastic Agent Market Challenges
8.4 Ophthalmic Viscoelastic Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ophthalmic Viscoelastic Agent Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Ophthalmic Viscoelastic Agent Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Ophthalmic Viscoelastic Agent Market Competitive Situation by Manufacturers in 2024
Table 4. Global Ophthalmic Viscoelastic Agent Sales (K Grams) of Key Manufacturers (2018-2023)
Table 5. Global Ophthalmic Viscoelastic Agent Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Ophthalmic Viscoelastic Agent Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Ophthalmic Viscoelastic Agent Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Ophthalmic Viscoelastic Agent Average Price (US$/Gram) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Ophthalmic Viscoelastic Agent, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Product Type & Application
Table 12. Global Key Manufacturers of Ophthalmic Viscoelastic Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ophthalmic Viscoelastic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Viscoelastic Agent as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ophthalmic Viscoelastic Agent Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Ophthalmic Viscoelastic Agent Sales by Region (2018-2023) & (K Grams)
Table 18. Global Ophthalmic Viscoelastic Agent Sales Market Share by Region (2018-2023)
Table 19. Global Ophthalmic Viscoelastic Agent Sales by Region (2024-2034) & (K Grams)
Table 20. Global Ophthalmic Viscoelastic Agent Sales Market Share by Region (2024-2034)
Table 21. Global Ophthalmic Viscoelastic Agent Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Ophthalmic Viscoelastic Agent Revenue Market Share by Region (2018-2023)
Table 23. Global Ophthalmic Viscoelastic Agent Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Ophthalmic Viscoelastic Agent Revenue Market Share by Region (2024-2034)
Table 25. North America Ophthalmic Viscoelastic Agent Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Ophthalmic Viscoelastic Agent Sales by Country (2018-2023) & (K Grams)
Table 27. North America Ophthalmic Viscoelastic Agent Sales by Country (2024-2034) & (K Grams)
Table 28. North America Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Ophthalmic Viscoelastic Agent Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Ophthalmic Viscoelastic Agent Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Ophthalmic Viscoelastic Agent Sales by Country (2018-2023) & (K Grams)
Table 32. Europe Ophthalmic Viscoelastic Agent Sales by Country (2024-2034) & (K Grams)
Table 33. Europe Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Ophthalmic Viscoelastic Agent Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Ophthalmic Viscoelastic Agent Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Ophthalmic Viscoelastic Agent Sales by Region (2018-2023) & (K Grams)
Table 37. Asia Pacific Ophthalmic Viscoelastic Agent Sales by Region (2024-2034) & (K Grams)
Table 38. Asia Pacific Ophthalmic Viscoelastic Agent Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Ophthalmic Viscoelastic Agent Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Ophthalmic Viscoelastic Agent Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Ophthalmic Viscoelastic Agent Sales by Country (2018-2023) & (K Grams)
Table 42. Latin America Ophthalmic Viscoelastic Agent Sales by Country (2024-2034) & (K Grams)
Table 43. Latin America Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Ophthalmic Viscoelastic Agent Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Ophthalmic Viscoelastic Agent Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Ophthalmic Viscoelastic Agent Sales by Country (2018-2023) & (K Grams)
Table 47. Middle East & Africa Ophthalmic Viscoelastic Agent Sales by Country (2024-2034) & (K Grams)
Table 48. Middle East & Africa Ophthalmic Viscoelastic Agent Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Ophthalmic Viscoelastic Agent Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Ophthalmic Viscoelastic Agent Sales (K Grams) by Type (2018-2023)
Table 51. Global Ophthalmic Viscoelastic Agent Sales (K Grams) by Type (2024-2034)
Table 52. Global Ophthalmic Viscoelastic Agent Sales Market Share by Type (2018-2023)
Table 53. Global Ophthalmic Viscoelastic Agent Sales Market Share by Type (2024-2034)
Table 54. Global Ophthalmic Viscoelastic Agent Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Ophthalmic Viscoelastic Agent Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Ophthalmic Viscoelastic Agent Revenue Market Share by Type (2018-2023)
Table 57. Global Ophthalmic Viscoelastic Agent Revenue Market Share by Type (2024-2034)
Table 58. Global Ophthalmic Viscoelastic Agent Price (US$/Gram) by Type (2018-2023)
Table 59. Global Ophthalmic Viscoelastic Agent Price (US$/Gram) by Type (2024-2034)
Table 60. Global Ophthalmic Viscoelastic Agent Sales (K Grams) by Application (2018-2023)
Table 61. Global Ophthalmic Viscoelastic Agent Sales (K Grams) by Application (2024-2034)
Table 62. Global Ophthalmic Viscoelastic Agent Sales Market Share by Application (2018-2023)
Table 63. Global Ophthalmic Viscoelastic Agent Sales Market Share by Application (2024-2034)
Table 64. Global Ophthalmic Viscoelastic Agent Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Ophthalmic Viscoelastic Agent Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Ophthalmic Viscoelastic Agent Revenue Market Share by Application (2018-2023)
Table 67. Global Ophthalmic Viscoelastic Agent Revenue Market Share by Application (2024-2034)
Table 68. Global Ophthalmic Viscoelastic Agent Price (US$/Gram) by Application (2018-2023)
Table 69. Global Ophthalmic Viscoelastic Agent Price (US$/Gram) by Application (2024-2034)
Table 70. Alcon Inc Corporation Information
Table 71. Alcon Inc Description and Business Overview
Table 72. Alcon Inc Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 73. Alcon Inc Ophthalmic Viscoelastic Agent Product
Table 74. Alcon Inc Recent Developments/Updates
Table 75. Shanghai Haohai Biological Technology Corporation Information
Table 76. Shanghai Haohai Biological Technology Description and Business Overview
Table 77. Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 78. Shanghai Haohai Biological Technology Ophthalmic Viscoelastic Agent Product
Table 79. Shanghai Haohai Biological Technology Recent Developments/Updates
Table 80. Bausch & Lomb Inc Corporation Information
Table 81. Bausch & Lomb Inc Description and Business Overview
Table 82. Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 83. Bausch & Lomb Inc Ophthalmic Viscoelastic Agent Product
Table 84. Bausch & Lomb Inc Recent Developments/Updates
Table 85. Abbott Medical Optics,Inc. Corporation Information
Table 86. Abbott Medical Optics,Inc. Description and Business Overview
Table 87. Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 88. Abbott Medical Optics,Inc. Ophthalmic Viscoelastic Agent Product
Table 89. Abbott Medical Optics,Inc. Recent Developments/Updates
Table 90. LG Life Sciences Corporation Information
Table 91. LG Life Sciences Description and Business Overview
Table 92. LG Life Sciences Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 93. LG Life Sciences Ophthalmic Viscoelastic Agent Product
Table 94. LG Life Sciences Recent Developments/Updates
Table 95. Johnson & Johnson Vision Corporation Information
Table 96. Johnson & Johnson Vision Description and Business Overview
Table 97. Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson Vision Ophthalmic Viscoelastic Agent Product
Table 99. Johnson & Johnson Vision Recent Developments/Updates
Table 100. Zeiss Corporation Information
Table 101. Zeiss Description and Business Overview
Table 102. Zeiss Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 103. Zeiss Ophthalmic Viscoelastic Agent Product
Table 104. Zeiss Recent Developments/Updates
Table 105. Ellex Medical Laser Limited Corporation Information
Table 106. Ellex Medical Laser Limited Description and Business Overview
Table 107. Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 108. Ellex Medical Laser Limited Ophthalmic Viscoelastic Agent Product
Table 109. Ellex Medical Laser Limited Recent Developments/Updates
Table 110. Huvitz Co., Ltd. Corporation Information
Table 111. Huvitz Co., Ltd. Description and Business Overview
Table 112. Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 113. Huvitz Co., Ltd. Ophthalmic Viscoelastic Agent Product
Table 114. Huvitz Co., Ltd. Recent Developments/Updates
Table 115. Iridex Corp. Corporation Information
Table 116. Iridex Corp. Description and Business Overview
Table 117. Iridex Corp. Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 118. Iridex Corp. Ophthalmic Viscoelastic Agent Product
Table 119. Iridex Corp. Recent Developments/Updates
Table 120. Lumenis Ltd. Corporation Information
Table 121. Lumenis Ltd. Description and Business Overview
Table 122. Lumenis Ltd. Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 123. Lumenis Ltd. Ophthalmic Viscoelastic Agent Product
Table 124. Lumenis Ltd. Recent Developments/Updates
Table 125. Nidek Co. Ltd Corporation Information
Table 126. Nidek Co. Ltd Description and Business Overview
Table 127. Nidek Co. Ltd Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 128. Nidek Co. Ltd Ophthalmic Viscoelastic Agent Product
Table 129. Nidek Co. Ltd Recent Developments/Updates
Table 130. Topcon Corporation Corporation Information
Table 131. Topcon Corporation Description and Business Overview
Table 132. Topcon Corporation Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 133. Topcon Corporation Ophthalmic Viscoelastic Agent Product
Table 134. Topcon Corporation Recent Developments/Updates
Table 135. Visionix Ltd Corporation Information
Table 136. Visionix Ltd Description and Business Overview
Table 137. Visionix Ltd Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 138. Visionix Ltd Ophthalmic Viscoelastic Agent Product
Table 139. Visionix Ltd Recent Developments/Updates
Table 140. Eyebright Medical Corporation Information
Table 141. Eyebright Medical Description and Business Overview
Table 142. Eyebright Medical Ophthalmic Viscoelastic Agent Sales (K Grams), Revenue (US$ Million), Price (US$/Gram) and Gross Margin (2018-2023)
Table 143. Eyebright Medical Ophthalmic Viscoelastic Agent Product
Table 144. Eyebright Medical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Ophthalmic Viscoelastic Agent Distributors List
Table 148. Ophthalmic Viscoelastic Agent Customers List
Table 149. Ophthalmic Viscoelastic Agent Market Trends
Table 150. Ophthalmic Viscoelastic Agent Market Drivers
Table 151. Ophthalmic Viscoelastic Agent Market Challenges
Table 152. Ophthalmic Viscoelastic Agent Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ophthalmic Viscoelastic Agent
Figure 2. Global Ophthalmic Viscoelastic Agent Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Ophthalmic Viscoelastic Agent Market Share by Type in 2024 & 2034
Figure 4. Cohesive Viscoelastic Product Picture
Figure 5. Low Viscosity Dispersion Viscoelastic Product Picture
Figure 6. Global Ophthalmic Viscoelastic Agent Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Ophthalmic Viscoelastic Agent Market Share by Application in 2024 & 2034
Figure 8. Cataract Surgery
Figure 9. Myopia Surgery
Figure 10. Other
Figure 11. Global Ophthalmic Viscoelastic Agent Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Ophthalmic Viscoelastic Agent Market Size (2018-2034) & (US$ Million)
Figure 13. Global Ophthalmic Viscoelastic Agent Sales (2018-2034) & (K Grams)
Figure 14. Global Ophthalmic Viscoelastic Agent Average Price (US$/Gram) & (2018-2034)
Figure 15. Ophthalmic Viscoelastic Agent Report Years Considered
Figure 16. Ophthalmic Viscoelastic Agent Sales Share by Manufacturers in 2024
Figure 17. Global Ophthalmic Viscoelastic Agent Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Ophthalmic Viscoelastic Agent Players: Market Share by Revenue in 2024
Figure 19. Ophthalmic Viscoelastic Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Ophthalmic Viscoelastic Agent Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Ophthalmic Viscoelastic Agent Sales Market Share by Country (2018-2034)
Figure 22. North America Ophthalmic Viscoelastic Agent Revenue Market Share by Country (2018-2034)
Figure 23. United States Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Ophthalmic Viscoelastic Agent Sales Market Share by Country (2018-2034)
Figure 26. Europe Ophthalmic Viscoelastic Agent Revenue Market Share by Country (2018-2034)
Figure 27. Germany Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Ophthalmic Viscoelastic Agent Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Ophthalmic Viscoelastic Agent Revenue Market Share by Region (2018-2034)
Figure 34. China Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Ophthalmic Viscoelastic Agent Sales Market Share by Country (2018-2034)
Figure 44. Latin America Ophthalmic Viscoelastic Agent Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Ophthalmic Viscoelastic Agent Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Ophthalmic Viscoelastic Agent Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Ophthalmic Viscoelastic Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Ophthalmic Viscoelastic Agent by Type (2018-2034)
Figure 54. Global Revenue Market Share of Ophthalmic Viscoelastic Agent by Type (2018-2034)
Figure 55. Global Ophthalmic Viscoelastic Agent Price (US$/Gram) by Type (2018-2034)
Figure 56. Global Sales Market Share of Ophthalmic Viscoelastic Agent by Application (2018-2034)
Figure 57. Global Revenue Market Share of Ophthalmic Viscoelastic Agent by Application (2018-2034)
Figure 58. Global Ophthalmic Viscoelastic Agent Price (US$/Gram) by Application (2018-2034)
Figure 59. Ophthalmic Viscoelastic Agent Value Chain
Figure 60. Ophthalmic Viscoelastic Agent Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed